Scroll the plot sideways to view all data.
@@ -135,14 +135,14 @@ exclusively performed PCR-based analyses, not serological
-
+
-
+
-
+
-
+
-
+
-
+
diff --git a/content/english/dashboards/serology-statistics.md b/content/english/dashboards/serology-statistics.md
index 353939aa..09421e6a 100644
--- a/content/english/dashboards/serology-statistics.md
+++ b/content/english/dashboards/serology-statistics.md
@@ -180,6 +180,6 @@ Thålin. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers
-
-
-
+
+
+
diff --git a/content/english/dashboards/wastewater/covid_quantification/covid_quant_KTH.md b/content/english/dashboards/wastewater/covid_quantification/covid_quant_KTH.md
index b86dab56..0d403996 100644
--- a/content/english/dashboards/wastewater/covid_quantification/covid_quant_KTH.md
+++ b/content/english/dashboards/wastewater/covid_quantification/covid_quant_KTH.md
@@ -2,9 +2,11 @@
title: Amount of SARS-CoV-2 in wastewater (SEEC-KTH)
plotly: true
aliases:
- - /dashboards/wastewater/covid_quant_kth/
+ - /dashboards/wastewater/covid_quant_kth/
---
+
+
@@ -99,9 +101,9 @@ Cetecioglu, Z. G., Williams, C., Khatami, K., Atasoy, M., Nandy, P., Jafferali,
## Methods
- To correct for variations in population size and wastewater flow, the group quantifies the pepper mild mottle virus (PMMoV) using a modified version of the assay of [Zhang *et al.* (2006)](https://doi.org/10.1371/journal.pbio.0040003). PMMoV is an abundant RNA virus in human faeces and serves as an estimator of human faecal content ([Symonds *et al.*, 2019](https://doi.org/10.1371/journal.ppat.1007639)). SARS-like virus specific N3-primers ([Lu *et al.*, 2020](https://doi.org/10.3201/eid2608.201246)) with SYBR Green chemistry ([Perez-Zabaleta *et al.*, 2023](https://doi.org/10.1016/j.scitotenv.2022.160023)) are used to quantify SARS-CoV-2.
+To correct for variations in population size and wastewater flow, the group quantifies the pepper mild mottle virus (PMMoV) using a modified version of the assay of [Zhang _et al._ (2006)](https://doi.org/10.1371/journal.pbio.0040003). PMMoV is an abundant RNA virus in human faeces and serves as an estimator of human faecal content ([Symonds _et al._, 2019](https://doi.org/10.1371/journal.ppat.1007639)). SARS-like virus specific N3-primers ([Lu _et al._, 2020](https://doi.org/10.3201/eid2608.201246)) with SYBR Green chemistry ([Perez-Zabaleta _et al._, 2023](https://doi.org/10.1016/j.scitotenv.2022.160023)) are used to quantify SARS-CoV-2.
-After concentration, filtering, and preparation, the samples are analysed using the qPCR technique for SARS CoV-2 RNA. Primers of the nucleocapsid (N) gene were used to detect the SARS-COV-2 gene (previously used and verified by [Medema *et al.* (2020)](https://doi.org/10.1021/acs.estlett.0c00357)). In some cases, raw wastewater samples were frozen at -20℃, and concentrated wastewater or purified RNA samples were sometimes stored at -80℃ before the next analysis step was carried out. The concentration method initially used by SEEC-KTH was based on one of their earlier studies ([Jafferali *et al.*, 2021](https://doi.org/10.1016/j.scitotenv.2020.142939)), which compared four different concentration methods. This method was used until week 35 of 2021. After this time, the group began to instead use [the Promega kit](https://se.promega.com/applications/virus-detection-assay-coronavirus-detection-covid-19-sars-cov-2/wastewater-based-epidemiology-covid19/) for the concentration step.
+After concentration, filtering, and preparation, the samples are analysed using the qPCR technique for SARS CoV-2 RNA. Primers of the nucleocapsid (N) gene were used to detect the SARS-COV-2 gene (previously used and verified by [Medema _et al._ (2020)](https://doi.org/10.1021/acs.estlett.0c00357)). In some cases, raw wastewater samples were frozen at -20℃, and concentrated wastewater or purified RNA samples were sometimes stored at -80℃ before the next analysis step was carried out. The concentration method initially used by SEEC-KTH was based on one of their earlier studies ([Jafferali _et al._, 2021](https://doi.org/10.1016/j.scitotenv.2020.142939)), which compared four different concentration methods. This method was used until week 35 of 2021. After this time, the group began to instead use [the Promega kit](https://se.promega.com/applications/virus-detection-assay-coronavirus-detection-covid-19-sars-cov-2/wastewater-based-epidemiology-covid19/) for the concentration step.
## Archived data
diff --git a/content/english/dashboards/wastewater/covid_quantification/covid_quant_SLU.md b/content/english/dashboards/wastewater/covid_quantification/covid_quant_SLU.md
index b8f8e010..4d7e8fcc 100644
--- a/content/english/dashboards/wastewater/covid_quantification/covid_quant_SLU.md
+++ b/content/english/dashboards/wastewater/covid_quantification/covid_quant_SLU.md
@@ -2,7 +2,7 @@
title: Amount of SARS-CoV-2 in wastewater (SEEC-SLU)
plotly: true
aliases:
- - /dashboards/wastewater/covid_quant_slu/
+ - /dashboards/wastewater/covid_quant_slu/
---
@@ -18,7 +18,7 @@ The data and visualisation on this page are usually updated weekly, typically on
## Wastewater collection sites
-SLU-SEEC collect and analyse samples from multiple areas. The below table shows details about each of these sites. The table lists the towns/cities monitored, wastewater treatment plants (WWTP) that samples were collected from, the number of people in the catchment area (Number of people), and the dates that monitoring by SLU-SEEC started and ended monitoring (Start and End date, respectively). A value of 'null' for the end date indicates that collection is ongoing. An asterisk next to the number of people indicates that the figure is preliminary.
+SLU-SEEC collect and analyse samples from multiple areas. The below table shows details about each of these sites. The table lists the towns/cities monitored, wastewater treatment plants (WWTP) that samples were collected from, the number of people in the catchment area (Number of people), and the dates that monitoring by SLU-SEEC started and ended monitoring (Start and End date, respectively). A value of 'null' for the end date indicates that collection is ongoing. An asterisk next to the number of people indicates that the figure is preliminary.
{{< plotly json="https://blobserver.dc.scilifelab.se/blob/wastewater_slusites.json" height="775px" >}}
@@ -62,7 +62,7 @@ SLU-SEEC collect and analyse samples from multiple areas. The below table shows
Last updated:
-
Important note: Historical data for Knivsta, Vaxholm, and Österåker are available in the dataset (linked below). However, they are no longer included in the visualisation.
+
Important note: Historical data for Ekerö, Enköping, Knivsta, Tierp, Vaxholm, Älvkarleby, and Österåker are available in the dataset (linked below). However, they are no longer included in the visualisation.
Please note that although the same methods are used for all cities shown on this tab, differences in the wastewater collection systems and populations of different cities might bias direct comparisons between cities.
@@ -109,13 +109,13 @@ Please note that although the same methods are used for all cities shown on this
## Reports from the research group
-The group provide reports to summarise their latest findings. The latest report is available [here](https://blobserver.dc.scilifelab.se/blob/Latest_weekly_report_SEEC-SLU) (only available in Swedish).
+The group provide reports to summarise their latest findings. The latest report is available [here](https://blobserver.dc.scilifelab.se/blob/Latest_weekly_report_SEEC-SLU.pdf) (only available in Swedish).
## Dataset
**Contact:**
and
-**Download the data:** [N1-gene copy number per PMMoV gene copy number, CSV file.](https://datagraphics.dckube.scilifelab.se/dataset/0ac8fa02871745048491de74e5689da9.csv). Data are available from week 38 of 2020; updated weekly.
+**Download the data:** [N1-gene copy number per PMMoV gene copy number, CSV file.](https://datagraphics.dc.scilifelab.se/dataset/0ac8fa02871745048491de74e5689da9.csv). Data are available from week 38 of 2020; updated weekly.
**How to cite the dataset:**
@@ -123,13 +123,13 @@ Székely, A. J., Vargas, J., Mohamed, N., Dafalla, I., Malmberg, M. (2021). Data
**How to cite the method:**
-Isaksson, F., Lundy, L., Hedström, A., Székely, A. J., Mohamed, N. (2022). Evaluating the Use of Alternative Normalization Approaches on SARS-CoV-2 Concentrations in Wastewater: Experiences from Two Catchments in Northern Sweden. *Environments*, *9*, 39. [https://doi.org/10.3390/environments9030039](https://doi.org/10.3390/environments9030039).
+Isaksson, F., Lundy, L., Hedström, A., Székely, A. J., Mohamed, N. (2022). Evaluating the Use of Alternative Normalization Approaches on SARS-CoV-2 Concentrations in Wastewater: Experiences from Two Catchments in Northern Sweden. _Environments_, _9_, 39. [https://doi.org/10.3390/environments9030039](https://doi.org/10.3390/environments9030039).
## Methods
For most cities represented on this page, raw, untreated wastewater samples that are representative of a single day are collected by flow compensated samplers at the wastewater treatment plants (WWTP). Uppsala is the exception, with all measurements since week 16 of 2021 instead representing 1 week. In Uppsala, samples are collected daily, and then combined flow-proportionally into one composite weekly sample for the purpose of analyses.
-The freshly collected samples are processed according to standard methodologies. For samples collected up to and including week 18 of 2021, viral particles were concentrated using the electronegative filtration method ([Ahmed *et al.*, 2020](https://www.sciencedirect.com/science/article/pii/S004896972033480X)). Since week 19 of 2021, the viral genomic material has instead been concentrated and extracted by the direct capture method, using the Maxwell RSC Enviro TNA kit (Promega). Absolute quantification of the copy numbers of the SARS-CoV-2 genome is performed using the [SARS-CoV-2 specific N1 assay from the Centers for Disease Control and Prevention (CDC)](https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html). To correct for variations in population size and wastewater flow, the group quantifies the pepper mild mottle virus (PMMoV) using a modified version of the assay of [Zhang *et al.* (2006)](https://doi.org/10.1371/journal.pbio.0040003). PMMoV is an abundant RNA virus in human faeces and serves as an estimator of human faecal content ([Symonds *et al.*, 2019](https://doi.org/10.1371/journal.ppat.1007639)). For more details about the sample processing method, and the evaluation of the use of the PMMoV normalisation method for Swedish wastewater, please refer to the corresponding publication: [Isaksson *et al.* (2022)](https://www.mdpi.com/2076-3298/9/3/39).
+The freshly collected samples are processed according to standard methodologies. For samples collected up to and including week 18 of 2021, viral particles were concentrated using the electronegative filtration method ([Ahmed _et al._, 2020](https://www.sciencedirect.com/science/article/pii/S004896972033480X)). Since week 19 of 2021, the viral genomic material has instead been concentrated and extracted by the direct capture method, using the Maxwell RSC Enviro TNA kit (Promega). Absolute quantification of the copy numbers of the SARS-CoV-2 genome is performed using the [SARS-CoV-2 specific N1 assay from the Centers for Disease Control and Prevention (CDC)](https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html). To correct for variations in population size and wastewater flow, the group quantifies the pepper mild mottle virus (PMMoV) using a modified version of the assay of [Zhang _et al._ (2006)](https://doi.org/10.1371/journal.pbio.0040003). PMMoV is an abundant RNA virus in human faeces and serves as an estimator of human faecal content ([Symonds _et al._, 2019](https://doi.org/10.1371/journal.ppat.1007639)). For more details about the sample processing method, and the evaluation of the use of the PMMoV normalisation method for Swedish wastewater, please refer to the corresponding publication: [Isaksson _et al._ (2022)](https://www.mdpi.com/2076-3298/9/3/39).
The data in the below graph and datafile represent the ratio of the copy numbers measured by the N1 and PMMoV-assays, multiplied by 104. As N1 copy number is a proxy for SARS-CoV-2 virus content in the wastewater and PMMoV is a proxy of the faecal content (which is related to the contributing population), the ratio of the two can be considered to be a proxy for the prevalence of COVID-19 infections in the population of the wastewater catchment area.
diff --git a/content/english/dashboards/wastewater/covid_quantification/historic_orebro_umea.md b/content/english/dashboards/wastewater/covid_quantification/historic_orebro_umea.md
index 8b5ba236..a8f37283 100644
--- a/content/english/dashboards/wastewater/covid_quantification/historic_orebro_umea.md
+++ b/content/english/dashboards/wastewater/covid_quantification/historic_orebro_umea.md
@@ -55,5 +55,5 @@ Malmberg, M., Myrmel, M. & Khatri, M. Dataset of SARS CoV-2 in wastewater in Ör
-
-
+
+
diff --git a/content/english/dashboards/wastewater/covid_quantification/historic_stockholm.md b/content/english/dashboards/wastewater/covid_quantification/historic_stockholm.md
index 8df6fdc8..56d1d833 100644
--- a/content/english/dashboards/wastewater/covid_quantification/historic_stockholm.md
+++ b/content/english/dashboards/wastewater/covid_quantification/historic_stockholm.md
@@ -34,4 +34,4 @@ Cetecioglu Z G, Williams, C, Khatami, K, Atasoy, M, Nandy, P, Jafferali, M H, Bi
-
+
diff --git a/content/english/privacy.md b/content/english/privacy.md
index 26e0ceba..89b860f8 100644
--- a/content/english/privacy.md
+++ b/content/english/privacy.md
@@ -16,7 +16,7 @@ We want to inform you that whenever you visit our **Service**, we collect inform
You can opt out of your Log Data being collected below:
-
+
## Forms
diff --git a/content/svenska/dashboards/npc-statistics.md b/content/svenska/dashboards/npc-statistics.md
index 23faf81a..49fee61a 100644
--- a/content/svenska/dashboards/npc-statistics.md
+++ b/content/svenska/dashboards/npc-statistics.md
@@ -130,25 +130,25 @@ nödvändigtvis överens med data som publicerats via andra kanaler
av olika anledningar.
Datasetet som visualiseras i graferna finns tillgängligt
-[här](https://datagraphics.dckube.scilifelab.se/dataset/bbbaf64a25a1452287a8630503f07418).
+[här](https://datagraphics.dc.scilifelab.se/dataset/bbbaf64a25a1452287a8630503f07418).
Källkoden för graferna finns
-[här](https://datagraphics.dckube.scilifelab.se/graphic/ba0b27320fe74ad0aef59a26be6c37f1),
-[här](https://datagraphics.dckube.scilifelab.se/graphic/ddb1119aefce47d58d0b3a49e98b4fcc),
-[här](https://datagraphics.dckube.scilifelab.se/graphic/b31c50be59c84c93986c25b052115a65)
-och [här](https://datagraphics.dckube.scilifelab.se/graphic/9145856246004419983d39fcf56d9eb6).
+[här](https://datagraphics.dc.scilifelab.se/graphic/ba0b27320fe74ad0aef59a26be6c37f1),
+[här](https://datagraphics.dc.scilifelab.se/graphic/ddb1119aefce47d58d0b3a49e98b4fcc),
+[här](https://datagraphics.dc.scilifelab.se/graphic/b31c50be59c84c93986c25b052115a65)
+och [här](https://datagraphics.dc.scilifelab.se/graphic/9145856246004419983d39fcf56d9eb6).
-
+
-
+
-
+
-
+
-
+
-
+
diff --git a/content/svenska/dashboards/post_covid.md b/content/svenska/dashboards/post_covid.md
index 1893772e..0031746b 100644
--- a/content/svenska/dashboards/post_covid.md
+++ b/content/svenska/dashboards/post_covid.md
@@ -209,8 +209,8 @@ Ett stort antal vetenskapliga artiklar, fallrapporter och reviews med fokus på
-
-
-
-
-
+
+
+
+
+
diff --git a/content/svenska/dashboards/serology-statistics.md b/content/svenska/dashboards/serology-statistics.md
index aafea675..bae31687 100644
--- a/content/svenska/dashboards/serology-statistics.md
+++ b/content/svenska/dashboards/serology-statistics.md
@@ -179,6 +179,6 @@ Thålin. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers
-
-
-
+
+
+
diff --git a/content/svenska/dashboards/wastewater/covid_quantification/covid_quant_KTH.md b/content/svenska/dashboards/wastewater/covid_quantification/covid_quant_KTH.md
index 4b86737d..fd91231e 100644
--- a/content/svenska/dashboards/wastewater/covid_quantification/covid_quant_KTH.md
+++ b/content/svenska/dashboards/wastewater/covid_quantification/covid_quant_KTH.md
@@ -2,9 +2,11 @@
title: Mängd SARS-COV-2 i avloppsvatten (SEEC-KTH)
plotly: true
aliases:
- - /sv/dashboards/wastewater/covid_quant_kth/
+ - /sv/dashboards/wastewater/covid_quant_kth/
---
+
+
@@ -12,7 +14,7 @@ aliases:
## Introduktion
-Projektet leds av professor Zeynep Cetecioglu Gurol med hjälp av Mariel Perez-Zabaleta and Isaac Owusu-Agyeman verksamna vid Kungliga Tekniska högskolan (KTH). Bioinformatikanalyser av avloppsvattendata sker i samarbete med professor Luisa Hugerth (Uppsala Universitet). Forskarsamarbetet utgör SEEC-KTH. SEEC-KTH är nu en del av [Institutionen för Industriell bioteknologi](https://www.kth.se/dib/department-of-industrial-biotechnology-1.783103) vid KTH. Projektet finansieras nu som en del av SciLifeLab Pandemic Laboratory Preparedness (PLP) program. Mer information om PLP-programmet finns i [resources section](/resources/).
+Projektet leds av professor Zeynep Cetecioglu Gurol med hjälp av Mariel Perez-Zabaleta and Isaac Owusu-Agyeman verksamna vid Kungliga Tekniska högskolan (KTH). Bioinformatikanalyser av avloppsvattendata sker i samarbete med professor Luisa Hugerth (Uppsala Universitet). Forskarsamarbetet utgör SEEC-KTH. SEEC-KTH är nu en del av [Institutionen för Industriell bioteknologi](https://www.kth.se/dib/department-of-industrial-biotechnology-1.783103) vid KTH. Projektet finansieras nu som en del av SciLifeLab Pandemic Laboratory Preparedness (PLP) program. Mer information om PLP-programmet finns i [resources section](/resources/).
Data och visualiseringar på den här sidan uppdateras vanligtvis veckovis, oftast på fredagar. Data bakom dashboarden uppdateras kontinuerligt.
@@ -99,9 +101,9 @@ Cetecioglu, Z. G., Williams, C., Khatami, K., Atasoy, M., Nandy, P., Jafferali,
## Metoder
-För att korrigera för variation i population och avloppsvattenflöde kvantifierar gruppen förekomsten av viruset Pepper mild mottle virus (PMMoV), ett växtvirus från peppar som människor får i sig via maten, med hjälp av en modifierad version av testet i [Zhang *et al.* (2006)](https://doi.org/10.1371/journal.pbio.0040003). PMMoV är det vanligaste RNA-viruset i avföring från människa och används för att uppskatta mängden avföring från människa i avloppsvattenproverna ([Symonds *et al.*, 2019](https://doi.org/10.1371/journal.ppat.1007639)). För att kvantifiera mängd SARS-CoV-2 används SARS-specifika N3-primers ([Lu *et al.*, 2020](https://doi.org/10.3201/eid2608.201246)) och mätningen görs med metoden RT-qPCR med SYBR Green-kemi ([Perez-Zabaleta *et al.*, 2023](https://doi.org/10.1016/j.scitotenv.2022.160023)).
+För att korrigera för variation i population och avloppsvattenflöde kvantifierar gruppen förekomsten av viruset Pepper mild mottle virus (PMMoV), ett växtvirus från peppar som människor får i sig via maten, med hjälp av en modifierad version av testet i [Zhang _et al._ (2006)](https://doi.org/10.1371/journal.pbio.0040003). PMMoV är det vanligaste RNA-viruset i avföring från människa och används för att uppskatta mängden avföring från människa i avloppsvattenproverna ([Symonds _et al._, 2019](https://doi.org/10.1371/journal.ppat.1007639)). För att kvantifiera mängd SARS-CoV-2 används SARS-specifika N3-primers ([Lu _et al._, 2020](https://doi.org/10.3201/eid2608.201246)) och mätningen görs med metoden RT-qPCR med SYBR Green-kemi ([Perez-Zabaleta _et al._, 2023](https://doi.org/10.1016/j.scitotenv.2022.160023)).
-Efter koncentration, filtrering och beredning analyseras proverna med RT-qPCR -teknik för att kvantifiera förekomsten av SARS-CoV-2 RNA. För att kvantifiera SARS-CoV-2 användes primers i nukleokapsid-(N)-genen (tidigare använt och verifierat av [Medema *et al.* (2020)](https://doi.org/10.1021/acs.estlett.0c00357)). I vissa fall har det obehandlade avloppsvattnet frusits vid –20 °C och koncentrerat avloppsvatten eller renat RNA har lagrats vid -80°C innan nästa analyssteg genomfördes. Koncentrationsmetoden som initialt användes av SEEC-KTH baseras på en av deras tidigare studier ([Jafferali *et al.*, 2021](https://doi.org/10.1016/j.scitotenv.2020.142939)), där fyra olika koncentrationsmetoder jämfördes. Denna metod användes fram till vecka 35, 2021. Efter denna tidpunkt började gruppen istället använda [Promegas kit](https://se.promega.com/applications/virus-detection-assay-coronavirus-detection-covid-19-sars-cov-2/wastewater-based-epidemiology-covid19/) för att koncentrera proverna.
+Efter koncentration, filtrering och beredning analyseras proverna med RT-qPCR -teknik för att kvantifiera förekomsten av SARS-CoV-2 RNA. För att kvantifiera SARS-CoV-2 användes primers i nukleokapsid-(N)-genen (tidigare använt och verifierat av [Medema _et al._ (2020)](https://doi.org/10.1021/acs.estlett.0c00357)). I vissa fall har det obehandlade avloppsvattnet frusits vid –20 °C och koncentrerat avloppsvatten eller renat RNA har lagrats vid -80°C innan nästa analyssteg genomfördes. Koncentrationsmetoden som initialt användes av SEEC-KTH baseras på en av deras tidigare studier ([Jafferali _et al._, 2021](https://doi.org/10.1016/j.scitotenv.2020.142939)), där fyra olika koncentrationsmetoder jämfördes. Denna metod användes fram till vecka 35, 2021. Efter denna tidpunkt började gruppen istället använda [Promegas kit](https://se.promega.com/applications/virus-detection-assay-coronavirus-detection-covid-19-sars-cov-2/wastewater-based-epidemiology-covid19/) för att koncentrera proverna.
## Arkiverade data
diff --git a/content/svenska/dashboards/wastewater/covid_quantification/covid_quant_SLU.md b/content/svenska/dashboards/wastewater/covid_quantification/covid_quant_SLU.md
index c73f925f..e405289c 100644
--- a/content/svenska/dashboards/wastewater/covid_quantification/covid_quant_SLU.md
+++ b/content/svenska/dashboards/wastewater/covid_quantification/covid_quant_SLU.md
@@ -2,7 +2,7 @@
title: Mängd SARS-COV-2 i avloppsvatten (SEEC-SLU)
plotly: true
aliases:
- - /sv/dashboards/wastewater/covid_quant_slu/
+ - /sv/dashboards/wastewater/covid_quant_slu/
---
@@ -18,7 +18,7 @@ Data och visualiseringar på den här sidan uppdateras vanligtvis veckovis, ofta
## Insamlingsplatser för avloppsvatten
-SLU-SEEC samlar in och analyserar prover från ett flertal orter/städer. Nedan visas en tabell med detaljerad information om alla insamlingsplatser. Tabellen listar orter/städer som monitoreras, avloppsreningsverk (WWTP) där proverna samlas in, antal personer i upptagningsområdet (antal invånare), mellan vilka datum SLU-SEEC mätningarna skett (startdatum och slutdatum). Ett värde ’null’ istället för slutdatum innebär att insamlingen fortfarande pågår. En asterisk bredvid antal invånare innebär att antal invånare är preliminärt.
+SLU-SEEC samlar in och analyserar prover från ett flertal orter/städer. Nedan visas en tabell med detaljerad information om alla insamlingsplatser. Tabellen listar orter/städer som monitoreras, avloppsreningsverk (WWTP) där proverna samlas in, antal personer i upptagningsområdet (antal invånare), mellan vilka datum SLU-SEEC mätningarna skett (startdatum och slutdatum). Ett värde ’null’ istället för slutdatum innebär att insamlingen fortfarande pågår. En asterisk bredvid antal invånare innebär att antal invånare är preliminärt.
{{< plotly json="https://blobserver.dc.scilifelab.se/blob/wastewater_slusites.json" height="775px" >}}
@@ -62,7 +62,7 @@ SLU-SEEC samlar in och analyserar prover från ett flertal orter/städer. Nedan
Senast uppdaterad:
-
Notera: Historisk data för Knivsta, Vaxholm och Österåker finns tillgänglig i det länkade datasetet ovan och ingår inte längre i visualiseringen nedan.
+
Notera: Historisk data för Ekerö, Enköping, Knivsta, Tierp, Vaxholm, Älvkarleby, och Österåker finns tillgänglig i det länkade datasetet ovan och ingår inte längre i visualiseringen nedan.
Notera också att även om samma metoder används för alla städer som visas på den här fliken, kan skillnader i befolkningen och hur avloppsvatten samlas in i olika städer påverka jämförelser dem emellan.
@@ -108,13 +108,13 @@ Notera också att även om samma metoder används för alla städer som visas p
## Rapporter från forskargruppen
-Forskargruppen delar även en rapport som sammanfattar den senaste informationen från deras avloppsvattenmätningar. Den senaste rapporten finns tillgänglig som pdf [här](https://blobserver.dc.scilifelab.se/blob/Latest_weekly_report_SEEC-SLU) (endast tillgänglig på svenska).
+Forskargruppen delar även en rapport som sammanfattar den senaste informationen från deras avloppsvattenmätningar. Den senaste rapporten finns tillgänglig som pdf [här](https://blobserver.dc.scilifelab.se/blob/Latest_weekly_report_SEEC-SLU.pdf) (endast tillgänglig på svenska).
## Dataset
**Kontakt:**
and
-**Ladda ner data:** [N1-gene copy number per PMMoV gene copy number, CSV file.](https://datagraphics.dckube.scilifelab.se/dataset/0ac8fa02871745048491de74e5689da9.csv). Data are available from week 38 of 2020; updated weekly.
+**Ladda ner data:** [N1-gene copy number per PMMoV gene copy number, CSV file.](https://datagraphics.dc.scilifelab.se/dataset/0ac8fa02871745048491de74e5689da9.csv). Data are available from week 38 of 2020; updated weekly.
**Hur man citerar dataset:**
@@ -122,13 +122,13 @@ Székely, A. J., Vargas, J., Mohamed, N., Dafalla, I., Malmberg, M. (2021). Data
**Hur man citerar metod:**
-Isaksson, F., Lundy, L., Hedström, A., Székely, A. J., Mohamed, N. (2022). Evaluating the Use of Alternative Normalization Approaches on SARS-CoV-2 Concentrations in Wastewater: Experiences from Two Catchments in Northern Sweden. *Environments*, *9*, 39. [https://doi.org/10.3390/environments9030039](https://doi.org/10.3390/environments9030039).
+Isaksson, F., Lundy, L., Hedström, A., Székely, A. J., Mohamed, N. (2022). Evaluating the Use of Alternative Normalization Approaches on SARS-CoV-2 Concentrations in Wastewater: Experiences from Two Catchments in Northern Sweden. _Environments_, _9_, 39. [https://doi.org/10.3390/environments9030039](https://doi.org/10.3390/environments9030039).
## Metoder
För de flesta städer på den här sidan samlas obehandlade avloppsvattenprover, representativa för en enskild dag, in av flödeskompenserade provtagare vid avloppsreningsverken (WWTP). Uppsala är undantaget, där alla mätningar sedan vecka 16 2021 istället representerar en vecka. Där samlas prover in dagligen och kombineras sedan flödesproportionellt till ett sammansatt veckoprov för följande analyser.
-Proverna bearbetas enligt standardmetoder. För prover som samlats in fram till och med vecka 18 2021 koncentrerades virala partiklar med hjälp av elektronegativ filtrering ([Ahmed *et al.*, 2020](https://www.sciencedirect.com/science/article/pii/S004896972033480X)). Från vecka 19 2021 har det virala genomiska materialet istället koncentrerats och extraherats med hjälp av en metod som använder Maxwell RSC Enviro TNA-kitet (Promega). Absolut kvantifiering av antalet kopior av SARS-CoV-2-genomet utförs med ett [SARS-CoV-2 specifikt N1-test från Centers for Disease Control and Prevention (CDC)](https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html). För att korrigera för variation i population och avloppsvattenflöde kvantifierar gruppen förekomsten av viruset Pepper mild mottle virus (PMMoV), ett växtvirus från peppar som människor får i sig via maten, med hjälp av en modifierad version av testet i [Zhang *et al.* (2006)](https://doi.org/10.1371/journal.pbio.0040003). PMMoV är det vanligaste RNA-viruset i avföring från människa och används för att uppskatta mängden avföring från människa i avloppsvattenprover ([Symonds *et al.*, 2019](https://doi.org/10.1371/journal.ppat.1007639)). För mer information om hur normaliseringsmetoden utvärderats se [Isaksson *et al.* (2022)](https://www.mdpi.com/2076-3298/9/3/39).
+Proverna bearbetas enligt standardmetoder. För prover som samlats in fram till och med vecka 18 2021 koncentrerades virala partiklar med hjälp av elektronegativ filtrering ([Ahmed _et al._, 2020](https://www.sciencedirect.com/science/article/pii/S004896972033480X)). Från vecka 19 2021 har det virala genomiska materialet istället koncentrerats och extraherats med hjälp av en metod som använder Maxwell RSC Enviro TNA-kitet (Promega). Absolut kvantifiering av antalet kopior av SARS-CoV-2-genomet utförs med ett [SARS-CoV-2 specifikt N1-test från Centers for Disease Control and Prevention (CDC)](https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html). För att korrigera för variation i population och avloppsvattenflöde kvantifierar gruppen förekomsten av viruset Pepper mild mottle virus (PMMoV), ett växtvirus från peppar som människor får i sig via maten, med hjälp av en modifierad version av testet i [Zhang _et al._ (2006)](https://doi.org/10.1371/journal.pbio.0040003). PMMoV är det vanligaste RNA-viruset i avföring från människa och används för att uppskatta mängden avföring från människa i avloppsvattenprover ([Symonds _et al._, 2019](https://doi.org/10.1371/journal.ppat.1007639)). För mer information om hur normaliseringsmetoden utvärderats se [Isaksson _et al._ (2022)](https://www.mdpi.com/2076-3298/9/3/39).
Data som presenteras i grafen är ett ratio av kopieantal som uppmätts med N1- och PMMoV-analyserna, multiplicerat med 10^4. N1-kopieantal är en proxy för mängd SARS-CoV-2 i avloppsvatten och PMMoV är en proxy för mängd avföring från människa, vilket i sin tur är relaterat till befolkningen som bidrar till avloppsvattnet. Detta ratio kan i sin tur anses vara en proxy för andelen infekterade individer i populationen i avloppsvattnets upptagningsområde.
diff --git a/content/svenska/dashboards/wastewater/covid_quantification/historic_orebro_umea.md b/content/svenska/dashboards/wastewater/covid_quantification/historic_orebro_umea.md
index 9d25bc9b..524cd329 100644
--- a/content/svenska/dashboards/wastewater/covid_quantification/historic_orebro_umea.md
+++ b/content/svenska/dashboards/wastewater/covid_quantification/historic_orebro_umea.md
@@ -53,5 +53,5 @@ Malmberg, M., Myrmel, M. & Khatri, M. Dataset of SARS CoV-2 in wastewater in Ör
-
-
+
+
diff --git a/content/svenska/dashboards/wastewater/covid_quantification/historic_stockholm.md b/content/svenska/dashboards/wastewater/covid_quantification/historic_stockholm.md
index ef772510..236cd98f 100644
--- a/content/svenska/dashboards/wastewater/covid_quantification/historic_stockholm.md
+++ b/content/svenska/dashboards/wastewater/covid_quantification/historic_stockholm.md
@@ -37,4 +37,4 @@ Cetecioglu Z G, Williams, C, Khatami, K, Atasoy, M, Nandy, P, Jafferali, M H, Bi
-
+
diff --git a/content/svenska/privacy.md b/content/svenska/privacy.md
index 015a211e..8b219b3c 100644
--- a/content/svenska/privacy.md
+++ b/content/svenska/privacy.md
@@ -17,7 +17,7 @@ Vi vill informera dig om att varje gång du besöker vår **tjänst** samlar vi
You can opt out of your Log Data being collected below:
-
+
## Formulär
diff --git a/data/available_datasets.json b/data/available_datasets.json
index 0343a81c..4a790f58 100644
--- a/data/available_datasets.json
+++ b/data/available_datasets.json
@@ -1,6 +1,171 @@
{
- "last_updated": "2023-05-04",
+ "last_updated": "2023-06-12",
"datasets": [
+ {
+ "doi": "10.3389/fpsyg.2023.1124627",
+ "available_items": [
+ {
+ "type": "data",
+ "repo_name": "OSF",
+ "accession_number": "d99ed5ce0ed641ca80965e54c11afc81",
+ "description": "Data used in analysis assessing personality traits",
+ "data_type": [
+ "Health data",
+ "Public health data",
+ "Social science and humanities data"
+ ],
+ "data_url": "https://osf.io/f7ucb/?view_only=d99ed5ce0ed641ca80965e54c11afc81"
+ },
+ {
+ "type": "code",
+ "repo_name": "OSF",
+ "accession_number": "d99ed5ce0ed641ca80965e54c11afc81",
+ "description": "Script for data re-analysis of traits",
+ "data_type": [
+ "Health data",
+ "Public health data",
+ "Social science and humanities data"
+ ],
+ "data_url": "https://osf.io/f7ucb/?view_only=d99ed5ce0ed641ca80965e54c11afc81"
+ }
+ ],
+ "title": "Regional differences in personalities account for substantial heterogeneity of loneliness change from before to during the COVID-19",
+ "issue": "",
+ "volume": "14",
+ "publisher": "Frontiers Media SA",
+ "published": "2023-05-05",
+ "author": [
+ "Xiao S.",
+ "Dang J."
+ ]
+ },
+ {
+ "doi": "10.1007/s41669-023-00418-x",
+ "available_items": [
+ {
+ "type": "code",
+ "repo_name": "GitHub",
+ "accession_number": "",
+ "description": "POETIC-COVID CEA PROJECT - R code that supports the findings of the study",
+ "data_type": [
+ "Other data",
+ "Public health data"
+ ],
+ "data_url": "https://github.com/EECCnetwork/POETIC_CEA"
+ }
+ ],
+ "title": "Cost Effectiveness of Strategies for Caring for Critically Ill Patients with COVID-19 in Tanzania",
+ "issue": "",
+ "volume": "",
+ "publisher": "Springer Science and Business Media LLC",
+ "published": "2023-05-13",
+ "author": [
+ "Shah H. A.",
+ "Baker T.",
+ "Schell C. O.",
+ "Kuwawenaruwa A.",
+ "Awadh K."
+ ]
+ },
+ {
+ "doi": "10.1038/s41467-023-38020-8",
+ "available_items": [
+ {
+ "type": "data",
+ "repo_name": "",
+ "accession_number": "",
+ "description": "Data cannot be shared publicly, but applications can be made for access.",
+ "data_type": [
+ "Serology data",
+ "Health data"
+ ],
+ "data_url": "mailto:\"geldmacher@lrz.uni-muenchen.de\""
+ }
+ ],
+ "title": "Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion",
+ "issue": "1",
+ "volume": "14",
+ "publisher": "Springer Science and Business Media LLC",
+ "published": "2023-05-24",
+ "author": [
+ "Eser T. M.",
+ "Baranov O.",
+ "Huth M.",
+ "Ahmed M. I. M.",
+ "Deák F."
+ ]
+ },
+ {
+ "doi": "10.1016/j.lanepe.2023.100646",
+ "available_items": [
+ {
+ "type": "code",
+ "repo_name": "GitHub",
+ "accession_number": "",
+ "description": "Data processing code is available on GitHub",
+ "data_type": [
+ "Serology data",
+ "Health data"
+ ],
+ "data_url": "https://github.com/johanssonresearch/Correlate-of-vaccine-protection-against-fatal-COVID-19"
+ }
+ ],
+ "title": "Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study",
+ "issue": "",
+ "volume": "",
+ "publisher": "Elsevier BV",
+ "published": "2023-05-15",
+ "author": [
+ "Vikström L.",
+ "Fjällström P.",
+ "Gwon Y.",
+ "Sheward D. J.",
+ "Wigren-Byström J."
+ ]
+ },
+ {
+ "doi": "10.1128/jvi.01992-22",
+ "available_items": [
+ {
+ "type": "data",
+ "repo_name": "zenodo",
+ "accession_number": "7826331",
+ "description": "Movies and data to accompany the study",
+ "data_type": [
+ "Imaging data",
+ "Biochemistry data",
+ "Genomics & transcriptomics data",
+ "Health data"
+ ],
+ "data_url": "https://zenodo.org/record/7826331"
+ },
+ {
+ "type": "code",
+ "repo_name": "GitHub",
+ "accession_number": "",
+ "description": "Image and time series analysis code written in MATLAB is available on GitHub",
+ "data_type": [
+ "Imaging data",
+ "Biochemistry data",
+ "Genomics & transcriptomics data",
+ "Health data"
+ ],
+ "data_url": "https://github.com/kassonlab/micrograph-spot-analysis"
+ }
+ ],
+ "title": "Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry",
+ "issue": "5",
+ "volume": "97",
+ "publisher": "American Society for Microbiology",
+ "published": "2023-05-31",
+ "author": [
+ "Sengar A.",
+ "Cervantes M.",
+ "Bondalapati S. T.",
+ "Hess T.",
+ "Kasson P. M."
+ ]
+ },
{
"doi": "10.1038/s41598-023-33168-1",
"available_items": [
diff --git a/data/events.json b/data/events.json
index 7248b8f1..be57c291 100644
--- a/data/events.json
+++ b/data/events.json
@@ -54,6 +54,30 @@
"registration_url": "https://fitwise.eventsair.com/pandemic2023/",
"description": "The conference is dedicated to accelerating the discovery, creation and equitable application of practical solutions to epidemic and pandemic threats worldwide.Over the last three years, the tireless work of the global scientific and research community in addressing COVID-19 has protected health systems, restored livelihoods and saved millions of lives.
These scientific advances and breakthroughs were built on many years of existing groundwork in pandemic science research. But they were also due to the innovation, partnerships, investment and new approaches rapidly deployed during the pandemic. How can we ensure these exceptional ways of working become business as usual in pandemic sciences?
The Conference’s 2023 theme, Making the Exceptional Routine, will explore how the level of innovation and multidisciplinary and multisectoral partnership we saw during COVID-19 can happen day-in, day-out to protect us from another devastating pandemic."
},
+ {
+ "title": "Call for new drug discovery pilot projects at SciLifeLab DDD with special emphasis on biologics and antibiotics",
+ "type": "Webinar",
+ "date_start": "2023-06-28",
+ "time_start": "11:00",
+ "time_end": "12:00",
+ "venue": "Online event",
+ "organisers": "Drug Discovery and Development Platform",
+ "event_url": "https://www.scilifelab.se/event/call-for-new-drug-discovery-pilot-projects-at-scilifelab-ddd-with-special-emphasis-on-biologics-and-antibiotics/",
+ "registration_url": "https://www.lyyti.in/Call_for_new_drug_discovery_pilot_projects_at_SciLifeLab_DDD_with_special_emphasis_onbiologics_and_antibiotics_6874",
+ "description": "Introductory talk for the call for new drug discovery pilot projects at SciLifeLab DDD with special emphasis on biologics and antibiotics."
+ },
+ {
+ "title": "ISIDORe joint webinar",
+ "type": "Webinar",
+ "date_start": "2023-06-27",
+ "time_start": "14:00",
+ "time_end": "15:00",
+ "venue": "Online event",
+ "organisers": "Infravet",
+ "event_url": "https://docs.google.com/forms/d/e/1FAIpQLSfSblsP9lZIpsxM23Eg5qYhrVmjV8fOQzpRdKW-kny8TIt9NA/viewform",
+ "registration_url": "https://docs.google.com/forms/d/e/1FAIpQLSfSblsP9lZIpsxM23Eg5qYhrVmjV8fOQzpRdKW-kny8TIt9NA/viewform",
+ "description": "Learn about the ISIDORe Epidemic Preparedness and Response Programme. Join the joint webinar between Infravec (Research infrastructures for control of vector-borne diseases), ERINHA (European Research Infrastructure on Highly Pathogenic Agents), VetBioNet (Veterinary Biocontained Research Facility Network)."
+ },
{
"title": "Nordic Conference of Antiviral Treatment Strategies and Drug Resistance",
"type": "Conference",
diff --git a/data/funding.json b/data/funding.json
index 0f0f8b1f..a0665170 100644
--- a/data/funding.json
+++ b/data/funding.json
@@ -1,83 +1,33 @@
{
- "last_updated": "2023-03-10",
+ "last_updated": "2023-06-15",
"calls": [
{
"topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Grant for research time in a clinical environment",
- "submission_deadline": "2023-03-28",
- "submission_opendate": "2023-02-22",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2022-11-10-grant-for-research-time-in-a-clinical-environment.html",
- "call_description": "The purpose of the grant is to give clinically active persons the opportunity to carry out research on a part-time basis in parallel with developing their clinical competence. The aim is to reinforce and renew medical and clinical research.",
- "applicant": "Individual researcher who completed a doctoral degree no more than 10 years ago.",
- "funding_period": "2-6 years starting Jan 2024.",
- "decision_date": "No later than the beginning of October 2023.",
- "funding_amount": "A standard amount based on the activity level (1 510 000 SEK per year, 1 680 000 SEK per year, or 1 850 000 SEK per year)."
- },
- {
- "topic": [
- "Infectious diseases",
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Project grant for research into viruses and pandemics – from fundamental mechanisms to medical interventions",
- "submission_deadline": "2023-03-28",
- "submission_opendate": "2023-02-22",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2022-11-10-project-grant-for-research-into-viruses-and-pandemics---from-fundamental-mechanisms-to-medical-interventions.html",
- "call_description": "The purpose of the project grant is to give researchers the freedom to formulate their own research idea, method and implementation, and to solve a specific research task within a limited period. The focus of this call is on research into basic virology and fundamental disease mechanisms caused by viruses. It also covers research into areas such as zoonoses, the development of medicines, vaccines, diagnostics and treatments. The initiative is part of the national research programme in viruses and pandemics.",
- "applicant": "Individual researcher and up to 6 other researchers may be invited to join the application",
- "funding_period": "1-3 years starting Jan 2024.",
- "decision_date": "No later than the beginning of November 2023.",
- "funding_amount": "Minimum 400 000 SEK per year, maximum 2 500 000 SEK per year."
- },
- {
- "topic": [
- "Infectious diseases",
- "Antibiotic resistance"
- ],
- "funder": "JPIAMR",
- "call_title": "Project grant for international research collaboration within antimicrobial resistance (Swedish project leader’s application in Prisma).",
- "submission_deadline": "2023-03-14",
- "submission_opendate": "2023-01-16",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2023-01-16-project-grant-for-international-research-collaboration-within-antimicrobial-resistance-jpiamr.html",
- "call_description": "The purpose of the grant is to support international collaboration in the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). This is the 16th call within JPIAMR and has the title “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance”. Sweden, via the Swedish Research Council, the Swedish International Development Cooperation Agency, is one of the 19 countries taking part in the JPIAMR call.",
- "applicant": "Individual researcher who participates as 1 of maximum 2 Swedish project leaders in a consortium with partners from at least 3 participating countries. Only researchers at an administrating organisation approved by the Swedish Research Council may apply.",
- "funding_period": "3 years starting Jan 2024.",
- "decision_date": "No later than the end of November 2023.",
- "funding_amount": "Minimum 1 200 000 SEK (approximately 110 000 EUR) in total per Swedish partner in a project. Maximum 3 500 000 SEK in total (approximately 320 000 EUR) per project for Swedish participation with maximum 2 Swedish partners. Maximum 5 000 000 SEK in total (approximately 457 000 EUR) for Swedish participation in a consortium with a Swedish coordinator."
- },
- {
- "topic": [
- "Infectious diseases",
- "Antibiotic resistance"
+ "General",
+ "Antibiotic resistance",
+ "Infectious diseases"
],
- "funder": "JPIAMR",
- "call_title": "Project grant for international research collaboration within antimicrobial resistance (consortium application to JPIAMR).",
- "submission_deadline": "2023-03-07",
- "submission_opendate": "2023-01-16",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2023-01-16-project-grant-for-international-research-collaboration-within-antimicrobial-resistance-jpiamr.html",
- "call_description": "The purpose of the grant is to support international collaboration in the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). This is the 16th call within JPIAMR and has the title “Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance”. Sweden, via the Swedish Research Council, the Swedish International Development Cooperation Agency, is one of the 19 countries taking part in the JPIAMR call.",
- "applicant": "Individual researcher who participates as 1 of maximum 2 Swedish project leaders in a consortium with partners from at least 3 participating countries. Only researchers at an administrating organisation approved by the Swedish Research Council may apply.",
- "funding_period": "3 years starting Jan 2024.",
- "decision_date": "No later than the end of November 2023.",
- "funding_amount": "Minimum 1 200 000 SEK (approximately 110 000 EUR) in total per Swedish partner in a project. Maximum 3 500 000 SEK in total (approximately 320 000 EUR) per project for Swedish participation with maximum 2 Swedish partners. Maximum 5 000 000 SEK in total (approximately 457 000 EUR) for Swedish participation in a consortium with a Swedish coordinator."
+ "funder": "SciLifeLab",
+ "call_title": "Call for new drug discovery pilot projects at SciLifeLab DDD with special emphasis on biologics and antibiotics",
+ "submission_deadline": "2023-08-24",
+ "submission_opendate": "2023-06-16",
+ "call_url": "https://anubis.scilifelab.se/call/DDD_Project_Call_summer_2023",
+ "call_description": "n this call, the Drug Discovery and Development Platform (DDD) at SciLifeLab is looking for new pilot project proposals for drug discovery. All therapeutic modalities outlined above are of interest. Of special interest are new project ideas for (multispecific) biologics, and in collaboration with ENABLE2 https://www.ilk.uu.se/enable2/, small molecule projects for discovery of new antibiotics.",
+ "applicant": "Scientists with a doctoral degree at a Swedish university or higher institution"
},
{
"topic": [
"Infectious diseases",
- "General"
+ "COVID-19"
],
- "funder": "Scandinavian Society of Antimicrobial Chemotherapy Foundation",
- "call_title": "Scandinavian Society of Antimicrobial Chemotherapy Foundation (SSAC Foundation) grants",
- "submission_deadline": "2023-02-01",
- "submission_opendate": "2022-12-01",
- "call_url": "https://www.sls.se/vetenskap/sok-anslag/ssac-foundation/",
- "call_description": "The Foundation distributes grants for research or travel related to the treatment of infectious diseases with antibacterial, antiviral, antimycotic or antiparasitic agents. The assets of the Foundation originates from the earnings of the 18th International Congress of Chemotherapy in Stockholm in 1993.",
- "applicant": "Applicants must be members of the Nordic Society of Clinical Microbiology and Infectious Diseases, NSCMID. The membership must have been granted no later than November 1st the year before the application.",
- "funding_period": "The grant should have been used by the end of December the year after the grant was received. Extension of the grant disposal time can only be approved under exceptional circumstances.",
- "decision_date": "Decisions on the grants will be communicated to the applicants via email by end of June."
+ "funder": "BY-COVID",
+ "call_title": "Support for the implementation of SARS-CoV-2 data hubs at national and regional levels",
+ "submission_deadline": "2023-09-01",
+ "submission_opendate": "2023-06-13",
+ "call_url": "https://by-covid.org/news/support-implementation-sars-cov2/",
+ "call_description": "The BY-COVID project has an open call for proposals to support the implementation of additional SARS-CoV-2 data hubs to increase the flow of viral sequence data into the European Nucleotide Archive (ENA), in line with open science principles.",
+ "applicant": "Legal entities, consortia, individual institutions, Scientists, public health professionals, (bio)informatics experts, funders, educational establishments.",
+ "funding_amount": "€60.000 maximum per awarded grant."
},
{
"topic": [
@@ -131,53 +81,6 @@
"submission_opendate": "2022-11-01",
"funding_amount": "Funding will be available for as long as it remains available. Call provides access to ISIDORe services, not a given monetary amount."
},
- {
- "topic": [
- "Infectious diseases",
- "General"
- ],
- "funder": "Hedlunds Stifelse",
- "call_title": "Medical Research",
- "call_url": "http://www.hedlundsstiftelse.se/ansokan/default_eng.htm",
- "call_description": "The overall objective of the call is to support research related to brain diseases (including psychiatry), infectious disease, and chronic inflammatory diseases.",
- "submission_deadline": "2023-01-31",
- "submission_opendate": "2022-11-01",
- "applicant": "A PhD researcher at a Swedish University/college conducting qualified medical research. The funds are paid out to the University/college.",
- "funding_period": "Applications are approved one year at a time for a maximum of 3 years.",
- "decision_date": "Following board meeting in April/May 2023."
- },
- {
- "topic": [
- "COVID-19",
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Welfare among Children and Young People in the Post-Pandemic Nordics",
- "call_url": "https://www.nordforsk.org/calls/call-research-project-proposals-welfare-among-children-and-young-people-post-pandemic-nordics?utm_source=Ungapped&utm_medium=Newsletter&utm_campaign=20220929",
- "call_description": "The overall objective of the call is to support and accelerate cutting edge Nordic research with high potential for renewal and impact on the welfare among children and young people in the post-pandemic Nordics. The call has an emphasis on education, wellbeing, mental health, and living conditions of children and young people.",
- "submission_deadline": "2022-12-08",
- "submission_opendate": "2022-09-16",
- "funding_amount": "NOK 11 million is the maximum amount of funding that may be sought",
- "applicant": "The research project must include partners from research performing organisations in at least three Nordic countries",
- "funding_period": "3-4 years",
- "decision_date": "Shortly after May 2023"
- },
- {
- "topic": [
- "Infectious diseases",
- "COVID-19"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Project grant for research into pandemics and their effects on society and public health",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2022-02-23-project-grant-for-research-into-pandemics-and-their-effects-on-society-and-public-health.html",
- "call_description": "The purpose of the project grant is to give researchers the freedom to formulate by themselves the research concept, method and implementation, and to solve a specific research task within a limited period. This is a project grant with focus, aimed at supporting research into pandemics and their effects on society and public health.",
- "submission_deadline": "2022-09-20",
- "submission_opendate": "2022-08-17",
- "funding_amount": "Minimum 400 000 SEK per year, maximum 1 700 000 SEK per year",
- "applicant": "Individual researcher",
- "funding_period": "1–3 years",
- "decision_date": "February 2023"
- },
{
"topic": [
"Infectious diseases",
@@ -190,359 +93,6 @@
"submission_deadline": "2022-11-29",
"submission_opendate": "2022-06-30",
"funding_amount": "Call provides access to ISIDORe services, not a given monetary amount."
- },
- {
- "topic": [
- "Infectious diseases",
- "Antibiotic resistance"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Proof of concept within the infection area",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2022-01-17-proof-of-concept-within-the-infection-area.html",
- "call_description": "The purpose of the grant is to bridge the gap between basic research and utilisation or commercialisation of research results within the infection area. The proof of concept grant offers persons who are receiving or have received a grant from the Swedish Research Council (Vetenskapsrådet), The Swedish Research Council for health, working life and welfare (Forte) or the Swedish Research Council for sustainable development (Formas) the opportunity to further develop their research results. This shall be done by verifying the useability and suitability of a new method, product or process developed from an earlier research project, and to carry out activities preparatory to innovation or commercialisation.",
- "submission_deadline": "2022-05-24",
- "submission_opendate": "2022-04-20",
- "funding_period": "1-2 years",
- "funding_amount": "500 000 SEK per year, maximum 2 000 000 SEK in total"
- },
- {
- "topic": [
- "Infectious diseases",
- "Antibiotic resistance"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Proof of concept within the infection area",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2022-01-17-proof-of-concept-within-the-infection-area.html",
- "call_description": "The purpose of the grant is to bridge the gap between basic research and utilisation or commercialisation of research results within the infection area. The proof of concept grant offers persons who are receiving or have received a grant from the Swedish Research Council (Vetenskapsrådet), The Swedish Research Council for health, working life and welfare (Forte) or the Swedish Research Council for sustainable development (Formas) the opportunity to further develop their research results. This shall be done by verifying the useability and suitability of a new method, product or process developed from an earlier research project, and to carry out activities preparatory to innovation or commercialisation.",
- "submission_deadline": "2022-05-24",
- "submission_opendate": "2022-04-20",
- "funding_period": "1-2 years",
- "funding_amount": "500 000 SEK per year, maximum 2 000 000 SEK in total"
- },
- {
- "topic": [
- "COVID-19",
- "Infectious diseases",
- "Antibiotic resistance"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Project grant for research into pandemics and their effects on society and public health",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2022-02-23-project-grant-for-research-into-pandemics-and-their-effects-on-society-and-public-health.html",
- "call_description": "The purpose of the project grant is to give researchers the freedom to formulate by themselves the research concept, method and implementation, and to solve a specific research task within a limited period. This is a project grant with focus, aimed at supporting research into pandemics and their effects on society and public health.",
- "submission_deadline": "2022-08-17",
- "submission_opendate": "2022-09-20"
- },
- {
- "topic": [
- "Antibiotic resistance"
- ],
- "funder": "JPIAMR",
- "call_title": "JPIAMR network call on Diagnostics and Surveillance",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2022-01-28-jpiamr-network-call-on-diagnostics-and-surveillance.html",
- "call_description": "The aim of this call is to assemble networks of leading experts and stakeholders with an intent to facilitate the development, optimisation and use of diagnostic and surveillance tools, technologies and systems. Networks should work towards the conceptualisation of ideas in order to provide white papers, guidance documents and/or best practices/roadmaps and evidence frameworks to identify key questions to be addressed and/or potential solutions to overcome barriers to enhanced surveillance and advanced diagnostics to reduce the burden of AMR.",
- "submission_deadline": "2022-06-22",
- "submission_opendate": "2022-04-12",
- "funding_period": "1-2 years",
- "funding_amount": "Maximum 500 000 SEK for a network",
- "decision_date": "No later than the beginning of November 2022"
- },
- {
- "topic": [
- "COVID-19"
- ],
- "funder": "NordForsk",
- "call_title": "Societal Security Beyond COVID-19",
- "submission_deadline": "2022-06-08",
- "call_url": "https://funding.nordforsk.org/portal/#call/2625/details",
- "call_description": "Projects in this call can address the medium to long-term effects for individuals and groups, for Nordic societies, and for the Nordic community, of the COVID-19 pandemic within the thematic framework of the call. Emphasis is placed on linking research and practice, and the involvement of various types of end users is encouraged to help strengthen the knowledge base for practice and for research-informed policy. The overarching theme of the call is to explore the medium to long-term consequences beyond the COVID-19 pandemic as they relate to societal security and the notion of a Nordic community, and how the Nordic countries can evolve together – or not together – for the future.",
- "applicant": "Individual researcher",
- "funding_period": "3–4 years",
- "funding_amount": "Maximum 9 000 000 NOK",
- "decision_date": "Late 2022"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "SciLifeLab",
- "call_title": "Call for new Pandemic Laboratory Preparedness capabilities (PLP-2)",
- "call_url": "https://www.scilifelab.se/pandemic-response/calls/call-for-new-pandemic-laboratory-preparedness-capabilities-plp-2/",
- "call_description": "The aim of this Expression of Interest (EoI) call is to develop services and capabilities that will facilitate laboratory pandemic preparedness and to address big questions within infectious diseases like antimicrobial resistance. Ideally these capabilities will be developed within or in close collaboration with current SciLifeLab infrastructure, but they can also include new proposals that could eventually form future SciLifeLab infrastructure services and units. The primary purpose of this call is technology development and adaptation to enable comprehensive monitoring and detection of pathogenic organisms, monitoring immune responses, analyzing antimicrobial resistance and studies of virulence mechanisms. The second purpose is to start services and prepare pipelines and practices for PLP data sharing capabilities together with the SciLifeLab Data Centre and national authorities (FoHM and others) that could be deployed in the case of the next pandemic. The third aim is to acquire sustainable support in collaboration with participating institutions to create sustainability of the pandemic preparedness.",
- "submission_deadline": "2022-05-02",
- "submission_opendate": "2022-03-11",
- "funding_period": "2 years",
- "funding_amount": "2 MSEK per year",
- "decision_date": "May and June 2022"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Consolidator grant within medicine and health",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2021-11-17-consolidator-grant-within-medicine-and-health.html",
- "call_description": "The purpose of the grant is to give the most prominent junior researchers the opportunity to consolidate their research and broaden their activities as independent researchers.",
- "submission_deadline": "2022-03-15",
- "submission_opendate": "2022-02-09",
- "funding_period": "5 years",
- "funding_amount": "2 000 000 SEK per year",
- "decision_date": "No later than the beginning of November 2022"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Starting grant within medicine and health",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2021-11-17-starting-grant-within-medicine-and-health.html",
- "call_description": "The aim of the grant is to give junior researchers the opportunity to establish themselves as independent researchers in Sweden.",
- "submission_deadline": "2022-03-15",
- "submission_opendate": "2022-02-09",
- "funding_period": "4 years",
- "funding_amount": "1 500 000 SEK per year",
- "decision_date": "No later than the beginning of November 2022"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Research project grant within medicine and health",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2021-11-17-research-project-grant-within-medicine-and-health.html",
- "call_description": "Project grant is to give researchers the freedom to formulate by themselves the research concept, method and implementation, and to solve a specific research task within a limited period.",
- "submission_deadline": "2022-03-15",
- "submission_opendate": "2022-02-09",
- "funding_period": "1-5 years",
- "funding_amount": "Minimum 400 000 SEK per year, maximum 2 500 000 SEK per year",
- "decision_date": "No later than the beginning of November 2022"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Grant for half-time research position in a clinical environment",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2021-11-17-grant-for-half-time-research-position-in-a-clinical-environment.html",
- "call_description": "A three-year grant to give clinically active persons the opportunity to conduct research on a half-time basis in parallel with developing their clinical skills.",
- "submission_deadline": "2022-03-15",
- "submission_opendate": "2022-02-09",
- "funding_period": "3 years",
- "funding_amount": "1 850 000 SEK per year",
- "decision_date": "No later than the beginning of November 2022"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "SSMF",
- "call_title": "SSMF Consolidator Grant",
- "call_url": "https://www.ssmf.se/for-scientists/consolidator-grant/",
- "call_description": "A five-year grant that gives prominent researchers the opportunity to strengthen their position as independent researchers.",
- "submission_deadline": "2022-04-15",
- "submission_opendate": "2022-03-15",
- "funding_period": "5 years",
- "funding_amount": "2 200 000 SEK per year, including indirect costs"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "SSMF",
- "call_title": "SSMF Starting Grant",
- "call_url": "https://www.ssmf.se/for-scientists/starting-grant/",
- "call_description": "SSMF’s four-year Starting Grant is intended to give promising young researchers the opportunity to establish themselves as independent researchers. This support is aimed at those with postdoctoral qualifications, and covers salaries and associated operating expenses. The grant can be used for research in all areas of medicine. SSMF supports both basic research and applied research.",
- "submission_deadline": "2022-04-15",
- "submission_opendate": "2022-03-15",
- "funding_period": "4 years",
- "funding_amount": "1 700 000 SEK per year, including indirect costs"
- },
- {
- "topic": [
- "Antibiotic resistance"
- ],
- "funder": "JPIAMR",
- "call_title": "Project grant for international research collaboration within antimicrobial resistance (JPIAMR)",
- "submission_deadline": "2022-03-15",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2021-12-03-project-grant-for-international-research-collaboration-within-antimicrobial-resistance-jpiamr.html",
- "call_description": "The purpose of the grant is to support international collaboration within the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). Sweden, via the Swedish Research Council, the Swedish International Development Cooperation Agency, and Vinnova is one of the 17 countries taking part in the call."
- },
- {
- "topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "International post doc grant within medicine and health (spring call)",
- "submission_deadline": "2022-02-22",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2021-11-17-international-post-doc-grant-within-medicine-and-health-spring-call.html",
- "call_description": "The purpose of the grant is to give researchers recently awarded a doctoral degree from a Swedish higher education institution (HEI) the opportunity to expand their networks and their competences by working abroad under secure employment conditions. The grant is also intended to promote the quality and renewal of Swedish research.",
- "applicant": "Individual researcher who completed a doctoral degree no more than 2 years ago, or who will have completed a doctoral degree before the start of the grant period, that is no later than 30 June 2022.",
- "funding_period": "1.5–3 years",
- "funding_amount": "1 150 000 SEK per year. A further total of 50 000 SEK per year may be applied for, for one or more accompanying family members",
- "decision_date": "No later than the beginning of June 2022"
- },
- {
- "topic": [
- "COVID-19"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Project grant for research into post-COVID",
- "submission_deadline": "2021-08-17",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2021-04-20-project-grant-for-research-within-post-covid-syndrome.html",
- "call_description": "The purpose of the project grant is to fund research into post-infectious conditions with remaining or late-onset symptoms following COVID-19 infection (post-COVID).",
- "applicant": "Individual researcher",
- "funding_period": "1–4 years. The entire grant amount will be paid out in 2021",
- "funding_amount": "Minimum 400 000 SEK per year, maximum 2 500 000 SEK per year",
- "decision_date": "No later than the beginning of December 2021"
- },
- {
- "topic": [
- "Infectious diseases"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Proof of concept within the infection area",
- "submission_deadline": "2021-08-17",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2021-04-21-proof-of-concept-within-the-infection-area.html",
- "call_description": "The purpose of the grant is to bridge the gap between basic research and commercialisation of research results within the infection area. The proof of concept grant offers persons who are receiving or have received a grant from the Swedish Research Council the opportunity to further develop their research results. This is done by verifying the usability and suitability of a new method, product or process developed from a previous research project and carrying out activities that prepare for innovation or commercialisation.",
- "applicant": "Individual researcher who is receiving or has received a grant from the Swedish Research Council with a grant period ending in 2019, 2020 or 2021.",
- "funding_period": "1-2 years",
- "funding_amount": "Minimum 500 000 SEK in total, maximum 2 000 000 SEK in total",
- "decision_date": "No later than the beginning of December 2021"
- },
- {
- "topic": [
- "Infectious diseases",
- "COVID-19"
- ],
- "funder": "Horizon Europe",
- "call_title": "FAIR and open data sharing in support to European preparedness for COVID-19 and other infectious diseases (HORIZON-INFRA-2021-EMERGENCY-01)",
- "submission_deadline": "2021-05-06",
- "call_url": "https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-infra-2021-emergency-01",
- "call_description": "This action responds to the need to enable researchers, health care professionals and society at large to share, access, analyse, link and process research data and other research digital objects across disciplines and national borders in response to the COVID-19 pandemic. As seen with other infectious disease outbreaks, such as haemorrhagic fevers, COVID-19 will likely remain a societal challenge beyond the immediate outbreak, considering its destructive and disruptive impact on healthcare systems and the economy. In addition to the ongoing health threat from SARS-CoV-2, the risk from other emerging pathogens also persists, which will also require similar concerted action to identify and characterise infections with pandemic potential, and enable rapid public health action to mitigate health and societal impact. Provision of comprehensive open data on infectious agents and diseases during outbreaks support evidence-based quality assessment - across scientific, medical, public health and policy domains and promotes reproducibility of research outcomes. Particular importance should be placed on mobilising raw viral sequences and identifying and monitoring the spread of SARS-CoV-2 variants. European readiness for future pandemics is of utmost importance and should be addressed to ensure the preparedness of infrastructure building on already existing frameworks for broader use such as the EOSC."
- },
- {
- "topic": [
- "Infectious diseases",
- "COVID-19"
- ],
- "funder": "Horizon Europe",
- "call_title": "Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics (HORIZON-INFRA-2021-EMERGENCY-02",
- "submission_deadline": "2021-05-06",
- "call_url": "https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-infra-2021-emergency-02",
- "call_description": "Proposals under this action, will integrate research infrastructure services to form a comprehensive and inclusive portfolio to support research in response to infectious disease epidemics or underpinning respective forefront research in the field. As a first immediate challenge, the delivered services should support research targeting newly emerging SARS-Cov-2 variants and addressing the on-going COVID-19 pandemic. Proposals will support the provision of trans-national and/or virtual access to researchers as well as training for using the infrastructures, and activities to improve, customise and integrate the services the infrastructures provide, so as to facilitate and integrate the access procedures and to further develop the remote or virtual provision of services."
- },
- {
- "topic": [
- "COVID-19"
- ],
- "funder": "Horizon Europe",
- "call_title": "Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment",
- "submission_deadline": "2021-05-06",
- "call_url": "https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2021-corona-01-01",
- "call_description": "Proposals submitted under this expression of interest should aim to further develop promising therapeutic or prophylactic candidates against SARS-CoV-2/COVID-19. The vaccine/treatment candidates should have completed preclinical development, including animal studies, and be ready to enter clinical evaluation in Phase I or II studies. Applicants should have addressed the current viral variants of concern in their pre-clinical work, and/or anticipated the emergence of new variants. Proposals should include a summary of results obtained in the concluded studies (pre-clinical and/or Phase I). Proposals are also expected to include assurances on sufficient and timely access to GMP production of the compound(s) to be trialled (the costs of which can be included in the proposal). In addition, options to upscale production for subsequent development beyond the activities for which funding is requested, should be indicated as appropriate."
- },
- {
- "topic": [
- "COVID-19"
- ],
- "funder": "Horizon Europe",
- "call_title": "Cohorts united against COVID-19 variants of concern",
- "submission_deadline": "2021-05-06",
- "call_url": "https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/horizon-hlth-2021-corona-01-02",
- "call_description": "Proposals submitted under this expression of interest are expected to build on existing large-scale, multi-centre, regional or international cohorts worldwide and/or establish new ones linked to those. These cohorts should aim to rapidly advance the knowledge on SARS-CoV-2 and its emerging variants of concern, with the aim of developing evidence-based strategic and robust recommendations for the effective control and prevention of COVID-19 infection. The regional or international cohort(s) should allow to rapidly and consistently provide estimations on the occurrence and spread of emerging variants of concern in different parts of the world. They should contribute to a better understanding of their transmissibility, virulence and pathogenicity."
- },
- {
- "topic": [
- "COVID-19"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Research environment grant for follow-up studies of COVID-19 vaccines",
- "submission_deadline": "2021-04-13",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2021-03-03-research-environment-grant-for-follow-up-studies-of-covid-19-vaccines.html",
- "call_description": "The purpose of the grant is to give researchers the opportunity to collaborate nationally to conduct follow-up studies of COVID-19 vaccine that are justified by the needs of health and medical care and that contribute to a permanent infrastructure for future follow-up studies.",
- "applicant": "Individual researcher with a clinical position covering a minimum of 20 per cent of a full-time equivalent",
- "funding_period": "3–4 years. The entire grant amount will be paid out in 2021",
- "funding_amount": "Minimum 10 million SEK in total, maximum 25 million SEK in total",
- "decision_date": "No later than end of June 2021"
- },
- {
- "topic": [
- "Infectious diseases"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Project grant for research on viruses and virus-caused disease conditions",
- "submission_deadline": "2021-03-17",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2020-11-10-project-grant-for-research-on-viruses-and-virus-caused-disease-conditions.html",
- "call_description": "The purpose is to give researchers the freedom to formulate their own research ideas, methods and implementation, and to solve a defined research task within a limited period of time. The focus of this call is on long-term research into basic virology and fundamental disease mechanisms caused by viruses.",
- "applicant": "Individual researcher",
- "funding_period": "1–3 years",
- "funding_amount": "Minimum 400 000 SEK per year, Maximum 2 500 000 SEK per year",
- "decision_date": "No later than the end of November 2021"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Research project grant within medicine and health",
- "submission_deadline": "2021-03-17",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2020-11-10-research-project-grant-within-medicine-and-health.html",
- "call_description": "The purpose of the project grant is to give researchers the freedom to formulate their own research idea, method and implementation, and to solve a specific research task within a limited period.",
- "applicant": "Individual researcher",
- "funding_period": "1–5 years",
- "funding_amount": "Minimum 400 000 SEK per year, Maximum 2 500 000 SEK per year",
- "decision_date": "No later than the end of November 2021"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Starting grant within medicine and health",
- "submission_deadline": "2021-03-17",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2020-11-10-starting-grant-within-medicine-and-health.html",
- "call_description": "The purpose of the grant is to give junior researchers the opportunity to establish themselves as independent researchers in Sweden.",
- "applicant": "Individual researcher who has completed a doctoral degree more than 2 years ago and up to 7 years ago.",
- "funding_period": "4 years",
- "funding_amount": "1 500 000 SEK per year",
- "decision_date": "No later than the beginning of November 2021"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Grant for half-time research position in a clinical environment",
- "submission_deadline": "2021-03-17",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2020-11-10-grant-for-half-time-research-position-in-a-clinical-environment.html",
- "call_description": "The purpose of the grant is to give clinically active persons the opportunity to conduct research on a half-time basis in parallel with developing their clinical skills. The aim is to reinforce and renew medical and clinical research.",
- "applicant": "Individual researcher who has completed a doctoral degree no more than 10 years ago.",
- "funding_period": "3 years (with the opportunity of a 3 year extension)",
- "funding_amount": "1 850 000 SEK per year",
- "decision_date": "No later than the beginning of November 2021"
- },
- {
- "topic": [
- "General"
- ],
- "funder": "Swedish Research Council",
- "call_title": "Swedish Research Council: Grant for half-time research within healthcare sciences",
- "submission_deadline": "2021-03-17",
- "call_url": "https://www.vr.se/english/applying-for-funding/calls/2020-11-10-grant-for-half-time-research-within-healthcare-sciences.html",
- "call_description": "The purpose of the grant is to give healthcare professionals the opportunity to conduct research on a half-time basis and to establish themselves as independent researchers in parallel with developing their professional competence. The call aims to promote international collaboration and mobility within Sweden.",
- "applicant": "Individual researcher who has completed a doctoral degree no more than 10 years ago.",
- "funding_period": "3 years",
- "funding_amount": "1 850 000 SEK per year",
- "decision_date": "No later than the beginning of November 2021"
- },
- {
- "topic": [
- "COVID-19"
- ],
- "funder": "SciLifeLab/KAW",
- "call_title": "COVID-19 pandemic research and preparedness",
- "submission_deadline": "2021-01-15",
- "call_url": "https://www.scilifelab.se/covid-19/call-research-preparedness/",
- "call_description": "SciLifeLab is opening five calls for proposals on COVID-19 research that are announced at the same time to help scientists plan their efforts in light of the funding possibilities. Two calls represent the continuation of the ongoing KAW-supported SciLifeLab coordinated COVID-19 research program initiated in the spring of 2020. One call is specifically targeting effects of vaccination. One call will focus on suggestions (letter of intent) for ideas on pandemic preparedness and one on suggestions for data-driven research on COVID-19 (letter of intent). 1. *Proposals from existing research areas (RAs) in the SciLifeLab-KAW COVID-19 program*, 2. *Proposals from individual scientists with new contributions to the SciLifeLab-KAW COVID-19 research program*, 3. *New KAW supported COVID-19 research program on vaccine effects*, 4. *Laboratory preparedness for pandemics*, 5. *Data-driven life science (DDLS) on COVID-19*."
}
]
}
\ No newline at end of file
diff --git a/layouts/contact/list.html b/layouts/contact/list.html
index a1aabbca..27d2d647 100644
--- a/layouts/contact/list.html
+++ b/layouts/contact/list.html
@@ -2,7 +2,7 @@
{{ .Content }}
-